• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Safety

  • Print
  • Share
  • E-mail

Premarin (conjugated estrogens tablets, USP)

Detailed View: Safety Labeling Changes Approved By FDA Center for Drug Evaluation and Research (CDER) – October 2011

 

Summary View

 

CONTRAINDICATIONS

  • ... angioedema
  • ... known thrombophilic disorders

 

WARNINGS

  • ... 7. angioedema
  • ... 8. hereditary angioedema

 

PPI

How should I take.....

  • added info about ...."tablet in stool"

 

also: selected sections changed to reflect recommended estrogen-class labeling